Claims extracted
16
sentences that state something as happening or true
Uncertain
31%
5 of 16 hedged
("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
67/100
New York Post's corrections and
hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
3
Health
Same framing elsewhere
1
articles that frame the event the way this one does
As more information is coming to light about one of the newest’s weight loss drug, the FDA’s Adverse Event Reporting System received reports of two deaths from bootleg versions of the medication.
asserted
System → come → medication
The products claimed to be the super-effective drug that’s nearing the end of clinical trials but has yet to be approved by the agency, making the deaths appear to be the first public accounts of unauthorized use in the US.
asserted
deaths → claim → US
While the commercial sale of unapproved drugs is prohibited, more are clamoring to get their hands on retatrutide — nicknamed “reta” — even before it’s legal, inspiring copycats of the unapproved drug on the gray peptide market.
asserted
it → prohibit → market
The first death, which occurred in July, involved a 41-year-old woman with obesity who suffered cardiac arrest.
asserted
who → occur → arrest
According to an FDA report from a healthcare professional that listed retatrutide as a “suspect product,” the woman had obtained the medication “from an unreliable source.”
uncertain
woman → accord → source
The agency received a second report in September of a 49-year-old patient who died after a licensed nurse “convinced” her to purchase the drug from an online peptide vendor.
asserted
nurse → receive → vendor
The victim experienced severe dehydration, malnutrition and cardiac arrest.
asserted
victim → experience → dehydration
An image from the report shows the medication appeared to be from a company called “AlphaLabs,” which offers peptides for “research use only,” according to screenshots from their website.
uncertain
which → show → website
“We review adverse event reports, gathering additional information when needed,” the FDA said in a statement, adding that it “generally does not discuss potential or ongoing compliance matters.”
While the reports don’t prove the newest weight loss medication was the cause of either death, they highlight potential dangers of obtaining an unapproved drug off an illicit market.
asserted
they → review → market
“The FDA should do whatever it possibly could do to get their hands on the actual drug that was injected by both of these patients,” associate professor at Harvard Medical School Pieter Cohen told CBS News.
uncertain
Cohen → do → News
“If the FDA is not aggressively investigating these cases, that’s deeply concerning.”
asserted
that → investigate → cases
In a July news release, the developer of the drug, Eli Lilly, said serious heart-related reactions “occurred less frequently than anticipated” in patients who received retatrutide, as well as those who got a placebo.
asserted
who → say → placebo
The statement also reported the drug reduced certain measures of cardiovascular risk.
asserted
drug → report → risk
The first of its kind to target three metabolic receptors (GLP-1, GIP and glucagon), retarutide has been shown to produce dramatically greater weight loss than blockbuster drugs like Ozempic and Mounjaro.
asserted
retarutide → target → Ozempic
Researchers reported back in May that users lost up to 28% of their body weight over 80 weeks, or about a year and a half.
uncertain
users → report → weeks
While the company plans to submit retatrutide for FDA approval in early 2027, the FDA’s review process could take up to a year before the drug hits the market, if approved.
uncertain
drug → plan → market
The Aporia
